MENU
+Compare
NDRA
Stock ticker: NASDAQ
AS OF
Nov 25 closing price
Price
$5.32
Change
+$0.58 (+12.24%)
Capitalization
6.21M

NDRA ENDRA Life Sciences Inc Forecast, Technical & Fundamental Analysis

ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care... Show more

Industry: #Biotechnology
NDRA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for NDRA with price predictions
Nov 25, 2025

NDRA's Stochastic Oscillator sits in oversold zone for 1 day

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 10-day moving average for NDRA crossed bullishly above the 50-day moving average on November 13, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where NDRA advanced for three days, in of 220 cases, the price rose further within the following month. The odds of a continued upward trend are .

NDRA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 80 cases where NDRA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 20, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on NDRA as a result. In of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for NDRA turned negative on November 21, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at .

NDRA moved below its 50-day moving average on November 20, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NDRA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NDRA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (36.232) is normal, around the industry mean (12.399). P/E Ratio (0.273) is within average values for comparable stocks, (139.674). NDRA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.978). NDRA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (0.000) is also within normal values, averaging (9.896).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NDRA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
NDRA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a developer of medical imaging technology solutions

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Biotechnology
Address
3600 Green Court
Phone
+1 734 335-0468
Employees
21
Web
https://www.endrainc.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ICG1.680.16
+10.53%
Intchains Group Limited
TCBX38.481.22
+3.27%
Third Coast Bancshares
BATRK38.890.84
+2.21%
Atlanta Braves Holdings
ASTI1.530.03
+2.00%
Ascent Solar Technologies Inc
MAA135.061.75
+1.31%
Mid-America Apartment Communities

NDRA and Stocks

Correlation & Price change

A.I.dvisor tells us that NDRA and GMED have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NDRA and GMED's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NDRA
1D Price
Change %
NDRA100%
+12.24%
GMED - NDRA
29%
Poorly correlated
+3.67%
ICUI - NDRA
24%
Poorly correlated
+2.30%
ICLR - NDRA
24%
Poorly correlated
+6.07%
NOTV - NDRA
24%
Poorly correlated
+3.91%
CNMD - NDRA
23%
Poorly correlated
-0.09%
More